Skip to main content

Advertisement

Log in

HIV-Related Mistrust (or HIV Conspiracy Theories) and Willingness to Use PrEP Among Black Women in the United States

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Uptake of pre-exposure prophylaxis (PrEP) among Black women living in the US is suboptimal. We sought to determine the association between HIV-related medical mistrust (or belief in HIV conspiracy theories) and willingness to use PrEP among Black women. We analyzed data from the 2016 National Survey on HIV in the Black Community (NSHBC), a nationally representative cross-sectional survey. Among NSHBC participants, 522 were women and 347 (69.0%) reported HIV risk factors. Only 14.1% were aware that PrEP exists; 30.8% reported willingness to use PrEP. HIV-related medical mistrust was reported by 60.4% of women. In multivariable analysis, controlling for income, education, marital status and health care engagement, belief in conspiracy theories was significantly associated with higher willingness to use PrEP. The HIV-Related Medical Mistrust Scale item: “there is a cure for HIV, but the government is withholding it from the poor” was independently associated with higher PrEP willingness. This finding speaks to the need for an improved understanding of the role of HIV-related medical mistrust among Black women to improve uptake of biomedical HIV prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Centers for Disease Control and Prevention. HIV Surveillance Report, 2018 (Preliminary); vol. 30. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published November 2019. Accessed 20 Feb 2020.

  2. McCree DH, Sutton M, Bradley E, Harris N. Changes in the disparity of HIV diagnosis rates among black women—United States, 2010–2014. MMWR Morb Mortal Wkly Rep. 2017;66(4):104–6.

    Article  Google Scholar 

  3. Baeten JM, Donnell D, Ndase P. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399–410.

    Article  CAS  Google Scholar 

  4. Marrazzo JM, Ramjee G, Richardson BA. Tenofovir-based pre-exposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372:509–18.

    Article  Google Scholar 

  5. Huang YA, Zhu W, Smith DK, Harris N, Hoover KW. HIV pre-exposure prophylaxis, by race and ethnicity—United States, 2014–2016. MMWR Morb Mortal Wkly Rep. 2018;67(41):1147–50.

    Article  Google Scholar 

  6. Ojikutu BO, Mayer KH. Hidden in plain sight: identifying women living in the US who could benefit from PrEP. J Infect Dis. 2019. https://doi.org/10.1093/infdis/jiz416.

    Article  PubMed  Google Scholar 

  7. Garfinkel DB, Alexander KA, McDonald-Mosley R, Willie TC, Decker MR. Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients. AIDS Care. 2017;29(6):751–8.

    Article  Google Scholar 

  8. Rutledge R, Madden L, Ogbuagu O, Meyer JP. HIV risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system. AIDS Care. 2018;30(10):1282–9.

    Article  Google Scholar 

  9. Lambert CC, Marrazzo J, Amico KR, Mugavero MJ, Elopre L. PrEParing women to prevent HIV: an integrated theoretical framework to PrEP Black women in the United States. J Assoc Nurses AIDS Care. 2018;29(6):835–48.

    Article  Google Scholar 

  10. Centers for Disease Control and Prevention: US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: a clinical practice guideline. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf. Published March 2018.

  11. Calabrese SK, Willie TC, Galvao RW, Tekeste M, Dovidio JF, Safon CB, et al. Current US guidelines for prescribing HIV pre-exposure prophylaxis (PrEP) disqualify many women who are at risk and motivated to use PrEP. J Acquir Immune Defic Syndr. 2019;81(4):395–405.

    Article  Google Scholar 

  12. Calabrese SK, Earnshaw VA, Underhill K, Hansen NB, Dovidio JF. The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access. AIDS Behav. 2014;18(2):226–40.

    Article  Google Scholar 

  13. Patel AS, Goparaju L, Sales JM, et al. Brief report: PrEP Eligibility among at-risk women in the southern United States: associated factors, awareness, and acceptability. J Acquir Immune Defic Syndr. 2019;80(5):527–32.

    Article  Google Scholar 

  14. Goparaju L, Praschan NC, Warren-Jeanpiere L, Experton LS, Young MA, Kassaye S. Stigma, partners, providers and costs: potential barriers to PrEP uptake among US women. J AIDS Clin Res. 2017;8(9):730.

    Article  Google Scholar 

  15. Ojikutu BO, Bogart LM, Mayer KH, Stopka TJ, Sullivan PS, Ransome Y. Spatial access and willingness to use pre-exposure prophylaxis among Black/African American individuals in the United States: cross-sectional survey. JMIR Public Health Surveill. 2019;5(1):e12405. https://doi.org/10.2196/12405.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Krakower DS, Mayer KH. The role of healthcare providers in the roll out of preexposure prophylaxis. Curr Opin HIV AIDS. 2016;11(1):41–8.

    Article  Google Scholar 

  17. Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA. PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS Behav. 2017;21(5):1256–67.

    Article  Google Scholar 

  18. Institute of Medicine Committee on Understanding Eliminating Racial Ethnic Disparities in Health Care. In: Smedley BD, Stith AY, Nelson AR, editors. Unequal treatment: confronting racial and ethnic disparities in health care. Washington: National Academies Press.

  19. Jaiswal J, Halkitis PN. Towards a more inclusive and dynamic understanding of medical mistrust informed by science. Behav Med. 2019;45(2):79–85.

    Article  Google Scholar 

  20. Armstrong K, McMurphy S, Dean LT, et al. Differences in the patterns of health care system distrust between blacks and whites. J Gen Intern Med. 2008;23(6):827–33.

    Article  Google Scholar 

  21. Jacobs EA, Rolle I, Ferrans CE, Whitaker EE, Warnecke RB. Understanding African Americans' views of the trustworthiness of physicians. J Gen Intern Med. 2006;21(6):642–7.

    Article  Google Scholar 

  22. LaVeist TA, Nickerson KJ, Bowie JV. Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Med Care Res Rev. 2000;57(Suppl 1):146–61.

    Article  Google Scholar 

  23. Halbert CH, Armstrong K, Gandy OH, Shaker L. Racial differences in trust in health care providers. Arch Intern Med. 2006;166(8):896–901.

    Article  Google Scholar 

  24. Musa D, Schulz R, Harris R, Silverman M, Thomas SB. Trust in the health care system and the use of preventive health services by older Black and White adults. Am J Public Health. 2009;99(7):1293–9.

    Article  Google Scholar 

  25. Cahill S, Taylor SW, Elsesser SA, Mena L, Hickson D, Mayer KH. Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts. AIDS Care. 2017;29(11):1351–8.

    Article  Google Scholar 

  26. Tekeste M, Hull S, Dovidio JF, et al. Differences in medical mistrust between Black and White women: implications for patient-provider communication about PrEP. AIDS Behav. 2019;23(7):1737–48.

    Article  Google Scholar 

  27. Goertzel T. Belief in conspiracy theories. Polit Psychol. 1994;15:731–42.

    Article  Google Scholar 

  28. Douglas KM, Sutton RM, Cichocka A. The psychology of conspiracy theories. Curr Dir Psychol Sci. 2017;26(6):538–42.

    Article  Google Scholar 

  29. Klonoff EA, Landrine H. Do blacks believe that HIV/AIDS is a government conspiracy against them? Prev Med. 1999;28:451–7.

    Article  CAS  Google Scholar 

  30. Bogart LM, Wagner G, Galvan FH, Banks D. Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among African-American men with HIV. J Acquir Immune Defic Syndr. 2010;53(5):648–55.

    Article  CAS  Google Scholar 

  31. Bogart LM, Thorburn S. Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? J Acquir Immune Defic Syndr. 2005;38(2):213–8.

    Article  Google Scholar 

  32. Hoyt MA, Rubin LR, Nemeroff CJ, Lee J, Huebner DM, Proeschold-Bell RJ. HIV/AIDS-related institutional mistrust among multiethnic men who have sex with men: effects on HIV testing and risk behaviors. Health Psychol. 2012;31(3):269–77.

    Article  Google Scholar 

  33. Bogart LM, Ransome Y, Higgins-Biddle M, Ojikutu BO. HIV-related medical mistrust and HIV testing in the National Survey on HIV in the Black Community. Behav Med. 2019;45(2):134–42.

    Article  Google Scholar 

  34. Bohnert AS, Latkin CA. HIV testing and conspiracy beliefs regarding the origins of HIV among African Americans. AIDS Patient Care STDS. 2009;23(9):759–63.

    Article  Google Scholar 

  35. Ford CL, Wallace SP, Newman PA, Lee S-J, Cunningham WE. Belief in AIDS-related conspiracy theories and mistrust in the government: relationship with HIV testing among at-risk older adults. Gerontologist. 2013;53(6):973084.

    Article  Google Scholar 

  36. Wyatt GE. Enhancing cultural and contextual intervention strategies to reduce HIV/AIDS among African Americans. Am J Public Health. 2009;99(11):1941–5.

    Article  Google Scholar 

  37. Bogart LM, Takada S, Cunningham WE. Medical mistrust, stigma, and the domestic HIV epidemic. HIV/AIDS in U.S. Communities of Color. Springer (to be published 2019).

  38. Ojikutu BO, Bogart LM, Higgins-Biddle M, Dale SK, Allen W, Dominique T, Mayer KH. Facilitators and barriers to pre-exposure Prophylaxis (PrEP) use among Black individuals in the United States: results from the National Survey on HIV in the Black Community (NSHBC). AIDS Behav. 2018;22(11):3576–87.

    Article  Google Scholar 

  39. Knowledge Networks Methodology. https://www.tessexperiments.org/data/zip/Simas675/Knowledge%20Networks%20Methodology.pdf (2019). Accessed 27 Jun 2019.

  40. Substance Use and Mental Health Services Administration (SAMHSA). AUDIT-C Overview. Available at: https://www.integration.samhsa.gov/images/res/tool_auditc.pdf (2019). Accessed 10 Sept 2019.

  41. Baliunas D, Rehm J, Irving H, Shuper P. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health. 2010;55(3):159–66.

    Article  Google Scholar 

  42. Hodder SL, Justman J, Hughes JP, Wang J, Haley DF, Adimora AA, HIV Prevention Trials Network 064; Women's HIV SeroIncidence Study Team, et al. HIV acquisition among women from selected areas of the United States. Ann Intern Med. 2013;158(1):10–8.

    Article  Google Scholar 

  43. Ivy W 3rd, Miles I, Le B, Paz-Bailey G. Correlates of HIV infection among African American women from 20 cities in the United States. AIDS Behav. 2014;18(Suppl 3):266–75.

    Article  Google Scholar 

  44. Raifman JR, Schwartz SR, Sosnowy CD, et al. Brief report: pre-exposure prophylaxis awareness and use among cisgender women at a sexually transmitted disease clinic. J Acquir Immune Defic Syndr. 2019;80(1):36–9.

    Article  Google Scholar 

  45. Koren DE, Nichols JS, Simoncini GM. HIV pre-exposure prophylaxis and women: survey of the knowledge, attitudes, and beliefs in an urban obstetrics/gynecology clinic. AIDS Patient Care STDS. 2018;32(12):490–4.

    Article  Google Scholar 

  46. Pringle K, Merchant RC, Clark MA. Is self-perceived HIV risk congruent with reported HIV risk among traditionally lower HIV risk and prevalence adult emergency department patients? Implications for HIV testing. AIDS Patient Care STDS. 2013;27(10):573–84.

    Article  Google Scholar 

  47. Klein H, Elifson KW, Sterk CE. "At risk" women who think that they have no chance of getting HIV: self-assessed perceived risks. Women Health. 2003;38:47–63.

    Article  Google Scholar 

  48. Jennings L, Rompalo AM, Wang J, Hughes J, Adimora AA, Hodder S, HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study (ISIS), et al. Prevalence and correlates of knowledge of male partner HIV testing and serostatus among African-American women living in high poverty, high HIV prevalence communities (HPTN 064). AIDS Behav. 2015;19(2):291–301.

    Article  Google Scholar 

Download references

Funding

This publication was made possible through funding from K23 MH107316 (BOO), the Harvard University Center for AIDS Research (CFAR), an NIH funded program (P30 AI060354) to support the effort of BOO and KHM, CHIPTS: P30MH058107 to support the work of LMB, and the National Institute of General Medical (NIGMS) Interdisciplinary Training Grant for Biostatisticians (T32 GM74905) who supported the effort of TFM.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. O. Ojikutu.

Ethics declarations

Conflict of interest

KHM reports receiving grants from Gilead Pharmaceuticals and from ViiV Healthcare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ojikutu, B.O., Amutah-Onukagha, N., Mahoney, T.F. et al. HIV-Related Mistrust (or HIV Conspiracy Theories) and Willingness to Use PrEP Among Black Women in the United States. AIDS Behav 24, 2927–2934 (2020). https://doi.org/10.1007/s10461-020-02843-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-020-02843-z

Keywords

Navigation